{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:45:55Z","timestamp":1790959555097,"version":"4.1.0"},"reference-count":51,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Although vaccines have been available for over a century, a correlate of protection for typhoid fever has yet to be identified. Antibodies are produced in response to typhoid infection and vaccination and are generally used as the gold standard for determining vaccine immunogenicity, even though their role in clearance of<jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Salmonella enterica<\/jats:named-content>serovar Typhi infections is poorly defined. Here, we describe the first functional characterization of<jats:italic>S.<\/jats:italic>Typhi-specific antibodies following vaccination with a new vaccine, M01ZH09 (Ty2 \u0394<jats:italic>aroC<\/jats:italic>\u0394<jats:italic>ssaV<\/jats:italic>). We determined that postvaccination sera increased the uptake of wild-type<jats:italic>S.<\/jats:italic>Typhi by human macrophages up to 2.3-fold relative to prevaccination (day 0) or placebo samples. These results were recapitulated using immunoglobulins purified from postvaccination serum, demonstrating that antibodies were largely responsible for increases in uptake. Imaging verified that macrophages internalized 2- to 9.5-fold more<jats:italic>S.<\/jats:italic>Typhi when the bacteria were opsonized with postvaccination sera than when the bacteria were opsonized with day 0 or placebo sera. Once inside macrophages, the survival of<jats:italic>S.<\/jats:italic>Typhi was reduced as much as 50% when opsonized with postvaccination sera relative to day 0 or placebo serum samples. Lastly, bactericidal assays indicated that antibodies generated postvaccination were recognized by complement factors and assisted in killing<jats:italic>S.<\/jats:italic>Typhi: mean postvaccination bactericidal antibody titers were higher at all time points than placebo and day 0 titers. These data clearly demonstrate that there are at least two mechanisms by which antibodies facilitate killing of<jats:italic>S.<\/jats:italic>Typhi. Future work could lead to improved immunogenicity tests associated with vaccine efficacy and the identification of correlates of protection against typhoid fever.<\/jats:p>","DOI":"10.1128\/iai.05081-11","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T03:44:13Z","timestamp":1306899853000},"page":"3188-3194","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":36,"title":["Antibodies in Action: Role of Human Opsonins in Killing Salmonella enterica Serovar Typhi"],"prefix":"10.1128","volume":"79","author":[{"given":"Janet C.","family":"Lindow","sequence":"first","affiliation":[{"name":"University of Vermont College of Medicine, Department of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, Vermont"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Fimlaid","sequence":"additional","affiliation":[{"name":"University of Vermont College of Medicine, Department of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, Vermont"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Y.","family":"Bunn","sequence":"additional","affiliation":[{"name":"University of Vermont College of Engineering and Mathematical Sciences, Burlington, Vermont"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth D.","family":"Kirkpatrick","sequence":"additional","affiliation":[{"name":"University of Vermont College of Medicine, Department of Medicine, Vaccine Testing Center and Unit of Infectious Diseases, Burlington, Vermont"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.75.3.214"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1259"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4049\/jimmunol.87.3.296","article-title":"Measurement of the opsonic effect of normal and immune sera on the phagocytosis of Salmonella Typhi by the reticuloendothelial system","volume":"87","author":"Biozzi G.","year":"1961","unstructured":"BiozziG.StiffelC.HalpernB. N.Le MinorL.MoutonD.. 1961. Measurement of the opsonic effect of normal and immune sera on the phagocytosis of Salmonella Typhi by the reticuloendothelial system. J. Immunol. 87:296\u2013300.","journal-title":"J. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.11.6586-6588.2004"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.6.1235"},{"key":"e_1_3_2_7_2","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump J.","year":"2004","unstructured":"CrumpJ. 2004. The global burden of typhoid fever. Bull. World Health Organ. 82:346\u2013353.","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_8_2","first-page":"467","article-title":"Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials","volume":"118","author":"Cryz S. J.","year":"1988","unstructured":"CryzS. J.Jr.Furer E.LevineM. M.. 1988. Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials. Schweiz. Med. Wochenschr. 118:467\u2013470.","journal-title":"Schweiz. Med. Wochenschr."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.3.1149-1151.1993"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.10.2731-2735.1988"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90056-R"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(89)80006-X"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2005.00360.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7125.110"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.08.027"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2009.31"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.2.236"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.6.1408"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1996.0074"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.4049\/jimmunol.160.3.1346","article-title":"Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B","volume":"160","author":"Jack D. L.","year":"1998","unstructured":"JackD. L.. 1998. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J. Immunol. 160:1346\u20131353.","journal-title":"J. Immunol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90194-5"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.08.008"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/431605"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00186-5"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00231-5"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92266-K"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2508(90)90114-6"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(01)01487-3"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104263441701"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.1.10-15.1996"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.005"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.017"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200310023491423"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/274808a0"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.2.451"},{"key":"e_1_3_2_36_2","first-page":"2636","volume-title":"Principles and practice of infectious disease","author":"Pegues D. A.","year":"2004","unstructured":"PeguesD. A.OhlM. E.MillerS. I.. 2004. Salmonella species, including Salmonella Typhi, p. 2636\u20132653. In MandellG. L.BennettJ. E.DolinR. (ed.), Principles and practice of infectious disease. Churchill-Livingstone, Philadelphia PA."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00245-09"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.Supplement_1.S106"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.1.362-368.2005"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807521"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1086\/518140"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/518135"},{"key":"e_1_3_2_43_2","first-page":"242","article-title":"Cellular immunity against Salmonella typhi after live oral vaccine","volume":"62","author":"Tagliabue A.","year":"1985","unstructured":"TagliabueA.. 1985. Cellular immunity against Salmonella typhi after live oral vaccine. Clin. Exp. Immunol. 62:242\u2013247.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.137.5.1504","article-title":"IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine","volume":"137","author":"Tagliabue A.","year":"1986","unstructured":"TagliabueA.. 1986. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. J. Immunol. 137:1504\u20131510.","journal-title":"J. Immunol."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00679.x"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.6.4058"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011778"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.11.006"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90335-2"},{"key":"e_1_3_2_50_2","unstructured":"WHO. 2003. posting date. Background document: the diagnosis treatment and prevention of typhoid fever. WHO WHO\/V&B\/03.07. http:\/\/www.who.int\/vaccines-documents."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2007.07.007"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00961-10"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.05081-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.05081-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T04:36:06Z","timestamp":1686112566000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.05081-11"}},"subtitle":[],"editor":[{"given":"A. J.","family":"B\u00e4umler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1128\/IAI.05081-11"],"URL":"https:\/\/doi.org\/10.1128\/iai.05081-11","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"2011-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-05-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}